ATE325089T1 - Krebsbehandlungsmittel für epithelzellen - Google Patents

Krebsbehandlungsmittel für epithelzellen

Info

Publication number
ATE325089T1
ATE325089T1 AT01944391T AT01944391T ATE325089T1 AT E325089 T1 ATE325089 T1 AT E325089T1 AT 01944391 T AT01944391 T AT 01944391T AT 01944391 T AT01944391 T AT 01944391T AT E325089 T1 ATE325089 T1 AT E325089T1
Authority
AT
Austria
Prior art keywords
epithelial cell
epithelial cells
cancer treatment
cell cancer
disilico
Prior art date
Application number
AT01944391T
Other languages
English (en)
Inventor
Harvey Kaufman
Original Assignee
Lifelink Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24367531&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE325089(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lifelink Pharmaceuticals Inc filed Critical Lifelink Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE325089T1 publication Critical patent/ATE325089T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B39/00—Compounds having molecular sieve and base-exchange properties, e.g. crystalline zeolites; Their preparation; After-treatment, e.g. ion-exchange or dealumination
    • C01B39/02—Crystalline aluminosilicate zeolites; Isomorphous compounds thereof; Direct preparation thereof; Preparation thereof starting from a reaction mixture containing a crystalline zeolite of another type, or from preformed reactants; After-treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Geology (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01944391T 2000-06-09 2001-06-08 Krebsbehandlungsmittel für epithelzellen ATE325089T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/591,701 US6288045B1 (en) 2000-06-09 2000-06-09 Epithelial cell cancer drug

Publications (1)

Publication Number Publication Date
ATE325089T1 true ATE325089T1 (de) 2006-06-15

Family

ID=24367531

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01944391T ATE325089T1 (de) 2000-06-09 2001-06-08 Krebsbehandlungsmittel für epithelzellen

Country Status (7)

Country Link
US (1) US6288045B1 (de)
EP (1) EP1289923B1 (de)
AT (1) ATE325089T1 (de)
AU (1) AU2001266807A1 (de)
DE (1) DE60119317T2 (de)
ES (1) ES2263629T3 (de)
WO (1) WO2001093877A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6579857B1 (en) * 1999-06-11 2003-06-17 Evanston Northwestern Healthcare Research Institute Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors
AT413484B (de) * 2002-02-26 2006-03-15 Hraschan Jakob Verwendung von zeolithen zur senkung der anteile von lactaten im menschlichen und tierischen organismus
US6890503B1 (en) 2002-04-30 2005-05-10 Minop Co. Silica additive for use in rubbers and similar cross-linked materials
EP1679962B1 (de) * 2003-10-20 2021-01-13 Framework Therapeutics, L.L.C. Zeolit-molekulare siebe für die entfernung von toxinen
US20060275505A1 (en) * 2005-06-06 2006-12-07 Ignacio Cisneros Method and composition for increasing the alkalinity of the body
WO2007011825A2 (en) * 2005-07-19 2007-01-25 Texas Enterosorbent, Inc. Preservative and additive for food and feed
WO2009052090A2 (en) * 2007-10-15 2009-04-23 7 Oaks Pharmaceutical Corporation Silicate containing compositions and methods of treatment
US20110059189A1 (en) * 2009-09-08 2011-03-10 Cisne Enterprises Inc. Method and composition for treating cancer, effecting apoptosis and treating retroviral infections
GB201402672D0 (en) 2014-02-14 2014-04-02 Medical Res Council Materials and methods relating to stabilised polymeric silicate compositions
US10828324B2 (en) 2014-10-09 2020-11-10 Nikolaos Tsirikos-Karapanos Production of water-soluble hydrolyzed clinoptilolite fragments
US10206948B2 (en) 2014-10-09 2019-02-19 Nikolaos Tsirikos-Karapanos Production of water-soluble clinoptilolite fragments
WO2016057057A1 (en) 2014-10-09 2016-04-14 Metron Nutraceuticals, Llc Production of water-soluble hydrolyzed clinoptilolite fragments for use in nutraceutical products
CN104606261B (zh) * 2015-03-05 2018-02-09 潘友长 一种沸石药物组合物及其制备方法和用途
US10894721B2 (en) * 2015-10-14 2021-01-19 Entox Solutions Llc Water-soluble electrolyzed/solvolyzed clinoptilolite fragments and nutraceutical, pharmaceutical, and environmental products based thereon
CN108403755A (zh) * 2018-05-03 2018-08-17 北京胜泰生物医药科技有限公司 一种沸石药物的组合、制备及用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017599A (en) * 1973-11-23 1977-04-12 Armour Pharmaceutical Company Aluminum-zirconium anti-perspirant systems with salts of amino acids
EP0154236B1 (de) * 1984-03-07 1988-01-13 IHARA CHEMICAL INDUSTRY Co., Ltd. Verfahren zur Herstellung von Halogenbenzol
US5252345A (en) * 1988-02-08 1993-10-12 Ethyl Corporation Zeolite compositions
DE19755921A1 (de) 1997-12-16 1999-06-17 Utp Dr Snyckers Gmbh Verfahren und Vorrichtung zur Verbesserung der Wirksamkeit von Wirkstoffen, die mindestens aus Mineralstoffen bestehen
CN1106806C (zh) * 1998-09-02 2003-04-30 南京大学 一种其烟雾中低亚硝胺含量的卷烟及其制法

Also Published As

Publication number Publication date
EP1289923B1 (de) 2006-05-03
DE60119317D1 (de) 2006-06-08
WO2001093877A2 (en) 2001-12-13
AU2001266807A1 (en) 2001-12-17
US6288045B1 (en) 2001-09-11
ES2263629T3 (es) 2006-12-16
EP1289923A2 (de) 2003-03-12
WO2001093877A3 (en) 2002-07-25
DE60119317T2 (de) 2007-05-16

Similar Documents

Publication Publication Date Title
ATE325089T1 (de) Krebsbehandlungsmittel für epithelzellen
MX249762B (es) Acidos aldonicos de oligosacarido y su uso topico.
MXPA05006194A (es) Metodo para utilizar una composicion de bebida.
HUP0105027A2 (hu) N-Heterociklusos vegyületek karbonsavszármazékai és karbonsav-izoszterei és alkalmazásuk
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
DE60022333D1 (de) Natrium kanalblocker zusammensetzungen und deren verwendung
BR0314699A (pt) Composto, composição e métodos para o tratamento da dor e para inibição da função vr1 em uma célula
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
MD960307A (ro) Compoziţii farmaceutice cu conţinut de acid hialuronic, utilizarea compoziţiilor pentru tratamentul bolilor pielii, metodă de tratament al bolilor pielii
MXPA02008770A (es) Compuestos azaciclicos para uso en el tratamiento de enfermedades relacionadas con la serotonina.
IL172705A0 (en) Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases
EP1119362A4 (de) Verwendungsmethode von tetracyclinverbindungen zur steigerung der interleukin-10 produktion
CY1109242T1 (el) Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου
BG106104A (en) Method for the treatment of diseases related to increased number of neutrophils or neutrophil overactivation
GB0130677D0 (en) Medicaments and novel compounds
EP1086099A4 (de) Sulfonsäure- oder sulfonylamino-n-(heteroaralkyl)-azaheterozyklylamidverbindungen
WO2002096362A3 (en) Method for treating fibrotic diseases or other indications vi
MXPA05003818A (es) Perfilamiento de la expresion genica de muestras ffpe.
BR9912279A (pt) Uso de uteroglobina humana recombinante no tratamento de condições inflamatórias e fibróticas
MXPA02012730A (es) Uso de acido pamoico o uno de sus derivados o uno de sus analogos para la preparacion de un medicamento para el tratamiento de enfermedades caracterizadas por depositos de agregados de amiloide.
ATE415965T1 (de) Verwendung von verzweigtkettigen fettsäuren und ihrer derivate zur schmerzbehandlung
SE0004101D0 (sv) New use
SE0100684D0 (sv) New subject-matter
SE0004462D0 (sv) Novel method and use
CA2077693A1 (en) Use of ketorolac for treatment of periodontal disease

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1289923

Country of ref document: EP

REN Ceased due to non-payment of the annual fee